Ticker Launch
Sign inTry it free

SPAC · Merger completed

CM Life Sciences III Inc.

Business combination with EQRx, Inc.

CM Life Sciences III Inc. is a blank-check company (SPAC) that raised $480M in its initial public offering on Apr 8, 2021, listing on Nasdaq Capital Market. It completed its business combination with EQRx, Inc. on Dec 17, 2021; the combined company is EQRx, Inc. (EQRX). White & Case advised the SPAC and Skadden, Arps advised the underwriters on the IPO.

EQRx is a pharmaceutical company that aims to develop and deliver patent-protected medicines to patients at much lower prices. It uses science, technology and partnerships across the healthcare system to provide medicines more efficiently and cost-effectively.

Status
Merger completed
IPO date
Apr 8, 2021
IPO size
$480M
IPO exchange
Nasdaq Capital Market
Target
EQRx, Inc.
Announced
Aug 6, 2021
Closed
Dec 17, 2021
Combined company
EQRx, Inc. (EQRX)
SPAC counsel (IPO)
White & Case
Underwriters' counsel (IPO)
Skadden, Arps

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021